News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Backed by a growing body of research, investigators at Dana-Farber Cancer Institute are calling for all hospitals to establish bereavement programs for families of deceased patients.

Tags: EndOfLife

  • New findings on prostate cancer from The Cancer Genome Atlas may enable doctors to make better diagnoses and prognoses for patients and provide novel directions for therapies.

Tags: Genomics, ProstateCancer

  • The Commonwealth Foundation for Cancer Research has pledged $20 million to the Bridge Project, a collaborative research program of the Koch Institute for Integrative Cancer Research at MIT and Dana-Farber/Harvard Cancer Center, to accelerate the translation of interdisciplinary cancer solutions toward the clinic.

Tags: BasicResearch

  • Turning off a single gene leads to a roughly three-to-five-fold gain in the yield of laboratory methods for producing red blood cells from stem cells, according to new research published in Cell Stem Cell. The findings suggest a way to cost-effectively manufacture red blood cells from stem cells; the patients who could potentially benefit include those who cannot use blood currently available in blood banks.

Tags: BasicResearch, ChildhoodCancer, Genomics

  • New research by Dana-Farber Cancer Institute scientists raises the prospect of cancer therapy that works by converting a tumor's best friends in the immune system into its gravest enemies.

Tags: BasicResearch, Immunotherapy

  • A new study charts the "genomic biography" of chronic lymphocytic leukemia, identifying gene mutations driving its growth, and tracing the shift in mutations as the disease progresses and develops resistance to chemotherapy, demonstrating the power of sequencing DNA in a large group of tumor tissue samples.

Tags: Genomics, Leukemia

  • Researchers link early prostate cancer to alterations in a program controlled by a "master regulator" of cell growth. This insight could open new avenues for preventing and treating prostate cancer.

Tags: BasicResearch, ProstateCancer

  • Disparities in outcomes for children with retinoblastoma — a rare eye tumor usually discovered in routine pediatric check-ups — suggest unequal access to primary care, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center report in a study published in the journal JAMA Pediatrics. Although virtually all the children in the study survived, Hispanic children and children who lived in disadvantaged areas were more likely to lose an eye due to late diagnosis.

Tags: ChildhoodCancer, ChildhoodCancerSurvivorship, Disparities

  • Dana-Farber is petitioning a federal court to determine that one of its scientists, Gordon Freeman, PhD, and another researcher are co-inventors on a series of cancer immunotherapy patents previously issued to a Japanese researcher and Japanese drug company.

  • Drugs that inhibit CDK7 may be a new therapy for treating triple-negative breast cancer.

Tags: BreastCancer

Showing 1-10 of 633 items